![](/img/cover-not-exists.png)
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
Lancet, J. E., Roboz, G. J., Cripe, L. D., Michelson, G. C., Fox, J. A., Leavitt, R. D., Chen, T., Hawtin, R., Craig, A. R., Ravandi, F., Maris, M. B., Stuart, R. K., Karp, J. E.Volume:
100
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2014.114769
Date:
February, 2015
File:
PDF, 1.57 MB
english, 2015